Percutaneous coronary intervention following thrombolysis: For whom and when?

Acute Cardiac Care

Volumn 11, Issue 4, 2009, Pages 195-203

  Taglieri, Nevio ^a   Di Mario, Carlo ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Fibrinolysis; Percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; RETEPLASE; TENECTEPLASE;

BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY RISK; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK REDUCTION; ST SEGMENT ELEVATION; THERAPY DELAY; TREATMENT FAILURE; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; EVIDENCE-BASED PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; REFERRAL AND CONSULTATION; RESEARCH DESIGN; RISK FACTORS; SALVAGE THERAPY; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 72049104803     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940903168191     Document Type: Review

References (56)

1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused update of the ACC/ AHA 2004 guidelines for the management of patients with stelevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines: Developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing group to review new evidence and update the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2008;117:296-329.
2. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
4. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med. 2000;342:1573-1580
5. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital delays in reperfusion for STelevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019-2025
6. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for STelevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006;367:579-588
7. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205-2217
8. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 2006;367:569-578
9. Aguirre FV, Varghese JJ, Kelley MP, LamW, Lucore CL, Gill JB, et al. Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program. Circulation. 2008;117: 1145-1152
10. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation. 2007;116:721-728
11. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: The Mayo Clinic STEMI Protocol. Circulation. 2007;116:729-736
12. Manari A, Ortolani P, Guastaroba P, Casella G, Vignali L, Varani E, et al. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: The Emilia-Romagna STsegment elevation acute myocardial infarction network. Eur Heart J. 2008;29:1834-1842
13. Saia F, Marrozzini C, Ortolani P, Palmerini T, Guastaroba P, Cortesi P, et al. Optimisation of therapeutic strategies for STsegment elevation acute myocardial infarction: The impact of a territorial network on reperfusion therapy and mortality. Heart. 2009;95:370-376
14. Madsen JK, Grande P, Saunamaki K, Thayssen P, Kassis E, Eriksen U, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in acute myocardial infarction. Circulation. 1997;96:748-755
15. van 't Hof AW, Ernst N, de Boer MJ, de Winter R, Boersma E, Bunt T, et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: Results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J. 2004;25:837-846
16. Lee DP, Herity NA, Hiatt BL, Fearon WF, Rezaee M, Carter AJ, et al. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: Results of the tirofiban given in the emergency room before primary angioplasty (TIGER-PA) pilot trial. Circulation. 2003;107:1497-1501
17. Gabriel HM, Oliveira JA, da Silva PC, da Costa JM, da Cunha JA. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: Results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Catheter Cardiovasc Interv. 2006;68:218-224
18. Pels K, Schroder J, Witzenbichler B, Muller D, Morguet A, Pauschinger M, et al. Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention. Eur J Emerg Med. 2008;15:324-329
19. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol. 2002;90: 533-536 (Pubitemid 35246047)
20. Cutlip DE, Ricciardi MJ, Ling FS, Carrozza JP, Jr, Dua V, Garringer J, et al. Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction. Am J Cardiol. 2003;92:977-980
21. GyongyosiM, Domanovits H, BenzerW, Haugk M, Heinisch B, Sodeck G, et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion* results of the Austrian multi-centre randomized ReoPro-BRIDGING Study. Eur Heart J. 2004;25:2125-2133
22. Zeymer U, Zahn R, Schiele R, Jansen W, Girth E, Gitt A, et al. Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. Eur Heart J. 2005;26:1971-1977
23. Bellandi F, Maioli M, Leoncini M, Toso A, Dabizzi RP. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention. Int J Cardiol. 2006;108:36-42.
24. O'Neill WW, Weintraub R, Grines CL, Meany TB, Brodie BR, Friedman HZ, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 1992;86:1710-1717
25. Fernandez-Aviles F, Alonso JJ, Pena G, Blanco J, onso- Briales J, Lopez-Mesa J, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: The GRACIA-2 noninferiority, randomized, controlled trial. Eur Heart J. 2007;28:949-960
26. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial. PACT investigators. Plasminogen- activator angioplasty compatibility trial. J Am Coll Cardiol. 1999;34:1954-1962
27. Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: A safety and feasibility study. Heart. 1999;82:426-431
28. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000;21:823-831
29. Facilitated percutaneous coronary intervention for acute STsegment elevation myocardial infarction: results from the prematurely terminated addressing the value of facilitated angioplasty after combination therapy or eptifibatide monotherapy in acute myocardial infarction (ADVANCE MI) trial. Am Heart J. 2005;150:116-122
30. Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, et al. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA. 2004;291: 947-954
31. De Luca G, Gibson CM, Bellandi F, Murphy M, Maioli M, Noc M, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis. Heart. 2008;94:1548-1558
32. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama- Lopez G, Lettieri C, et al. European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab*EUROTRANSFER Registry. Am Heart J. 2008;156:1147-1154
33. Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, et al. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. Eur Heart J. 2009;30:33-43.
34. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in STsegment elevation myocardial infarction: The Middlesbrough early revascularization to limit infarction (MERLIN) trial. J Am Coll Cardiol. 2004;44:287-296
35. Kunadian B, Sutton AG, Vijayalakshmi K, Thornley AR, Gray JC, Grech ED, et al. Early invasive versus conservative treatment in patients with failed fibrinolysis no late survival benefit: The final analysis of the Middlesbrough early revascularisation to limit infarction (MERLIN) randomized trial. Am Heart J. 2007;153:763-771
36. Sutton AG, Campbell PG, Graham R, Price DJA, Gray JC, Hall JA, et al. One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial. Heart. 2005;91:1330-1337
37. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353:2758-2768
38. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Phillips CO, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a metaanalysis of randomized trials. J Am Coll Cardiol. 2007;49: 422-430
39. Collet JP, Montalescot G, Le May M, Borentain M, Gershlick A. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol. 2006;48:1326-1335
40. Wijeysundera HC, You JJ, Nallamothu BK, Krumholz HM, Cantor WJ, Ko DT. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: A meta-analysis of contemporary randomized controlled trials. Am Heart J. 2008;156:564-572
41. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (which early ST-elevation myocardial infarction therapy) study. Eur Heart J. 2006;27:1530-1538
42. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, onso-Briales J, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): A randomised controlled trial. Lancet. 2004;364:1045-1053
43. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005;46:417-424
44. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 2003;42:634-641
45. Bednar F, Widimsky P, Krupicka J, Groch L, Aschermann M, Zelizko M. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol. 2003;19:1133-1137
46. Di Mario C, Dudek D, Piscione F, Mielecki W, Savonitto S, Murena E, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the combined abciximab reteplase stent study in acute myocardial infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371:559-68.
47. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001;357:1905-1914
48. Merlini PA, Repetto A, Andreoli AM, Ricci S, Lombardi A, Finardi A, et al. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase. Am J Cardiol. 2004;93:195-198
49. Cantor WJ, Fitchett D, Borgundvaag B, Heffernan M, Cohen EA, Morrison LJ, et al. Rationale and design of the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarction (TRANSFERAMI). Am Heart J. 2008;155:19-25.
50. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993;329:673-682
51. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76: 142-154
52. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189
53. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: The PCI-CLARITY study. JAMA. 2005;294: 1224-1232
54. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON- TIMI 38): Double-blind, randomised controlled trial. Lancet. 2009;373:723-731
55. Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res. 2007;100:1261-1275
56. Wang K, Zhou X, Zhou Z, Tarakji K, Carneiro M, Penn MS, et al. Blockade of the platelet P2Y12 receptor by ARC69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model. Arterioscler Thromb Vasc Biol. 2003;23: 357-362